Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection (Q109295345)

2

0 references

Marco Falasca

3

0 references

Valeria Caneapero

4

0 references

Giuseppe Cappellano

5

0 references

Davide Raineri

6

0 references

Marco Ghirimoldi

7

0 references

Veronica De Giorgis

8

0 references

Chiara Puricelli

9

0 references

Rosanna Vaschetto

10

0 references

Pier Paolo Sainaghi

11

0 references

Stefania Bruno

12

0 references

Antonio Sica

13

0 references

Umberto Dianzani

14

0 references

Roberta Rolla

15

0 references

Annalisa Chiocchetti

16

0 references

Vincenzo Cantaluppi

17

0 references

Gianluca Baldanzi

18

0 references

Emilio Marengo

19

0 references

Marcello Manfredi

Frontiers in molecular biosciences

20

0 references

language of work or name

English

0 references

publication date

2021

0 references

published in

0 references

volume

8

0 references

page(s)

632290

0 references

copyright license

Creative Commons Attribution 4.0 International

start time

22 February 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

SAA is a biomarker to distinguish the severity and prognosis of Coronavirus Disease 2019 (COVID-19)

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Acute Phase Proteins in Marine Mammals: State of Art, Perspectives and Challenges

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Complement as a target in COVID-19?

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Analysis of clinical features and imaging signs of COVID-19 with the assistance of artificial intelligence

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Association between markers of immune response at hospital admission and COVID-19 disease severity and mortality: A meta-analysis and meta-regression

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Sepsis biomarkers: a review

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

One-step RT-droplet digital PCR: a breakthrough in the quantification of waterborne RNA viruses

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

IL-12 and Viral Infections

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Exosome markers associated with immune activation and oxidative stress in HIV patients on antiretroviral therapy.

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Mass spectrometry-based proteome profiling of extracellular vesicles and their roles in cancer biology

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Extracellular Vesicles Mediate Mesenchymal Stromal Cell-Dependent Regulation of B Cell PI3K-AKT Signaling Pathway and Actin Cytoskeleton

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Extracellular vesicles and infectious diseases: new complexity to an old story

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Respiratory Syncytial Virus Infection Changes Cargo Composition of Exosome Released from Airway Epithelial Cells

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Inflammation-induced changes in expression and glycosylation of genetic variants of alpha 1-acid glycoprotein. Studies with human sera, primary cultures of human hepatocytes and transgenic mice.

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

CXCL7-induced macrophage infiltration in lung tumor is independent of CXCR2 expression: CXCL7-induced macrophage chemotaxis in LLC tumors

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Role of the inflammatory protein serine protease inhibitor Kazal in preventing cytolytic granule granzyme A-mediated apoptosis.

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Hyaluronan Receptor LYVE-1-Expressing Macrophages Maintain Arterial Tone through Hyaluronan-Mediated Regulation of Smooth Muscle Cell Collagen

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Fibrinogen promotes neutrophil activation and delays apoptosis

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Exosomal proteome analysis of human plasma to monitor sepsis progression.

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

C-reactive protein levels in the early stage of COVID-19

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

The case of Complement activation in COVID-19 multiorgan impact

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

The contribution of acute phase reaction proteins to the diagnosis and treatment of 2019 novel coronavirus disease (COVID-19)

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Multi-organ Dysfunction in Patients with COVID-19: A Systematic Review and Meta-analysis

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

The Role of Extracellular Vesicles in Viral Infection and Transmission

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

"War to the knife" against thromboinflammation to protect endothelial function of COVID-19 patients

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Novel Anti-Thrombotic Mechanisms Mediated by Mas Receptor as Result of Balanced Activities Between the Kallikrein/Kinin and the Renin-Angiotensin Systems

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

The Anti-Apoptotic Effect of ASC-Exosomes in an In Vitro ALS Model and Their Proteomic Analysis

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Reduced activity of B lymphocytes, recognised by Sysmex XN-2000™ haematology analyser, predicts mortality in patients with coronavirus disease 2019

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Hematological findings and complications of COVID-19

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Coronavirus infections and immune responses

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Proteomic and Metabolomic Characterization of COVID-19 Patient Sera

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Interleukin-6 as prognosticator in patients with COVID-19: IL-6 and Covid-19

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Serum proteomics in COVID-19 patients: Altered coagulation and complement status as a function of IL-6 level

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Chicken-or-egg question: Which came first, extracellular vesicles or autoimmune diseases?

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

The biology, function, and biomedical applications of exosomes

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Fibronectin in acute and chronic inflammation

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Neutrophil-Derived Exosomes: A New Mechanism Contributing to Airway Smooth Muscle Remodeling

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Hyperglycemia, Hydroxychloroquine, and the COVID-19 Epidemic

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Association between C-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Exosomes from high glucose-treated macrophages activate glomerular mesangial cells via TGF-β1/Smad3 pathway in vivo and in vitro

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Endothelial cell infection and endotheliitis in COVID-19

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

THE PRESENT AND FUTURE OF THE MASS SPECTROMETRY-BASED INVESTIGATION OF THE EXOSOME LANDSCAPE

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

A lesson from a saboteur: high molecular weight kininogen (HMWK) impact in COVID-19

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

A potential treatment of COVID-19 with TGF-β blockade

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

The role of extracellular vesicles in COVID-19 virus infection

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Spontaneous Major Hemorrhage in COVID-19 Patients: Another Brick in the Wall of SARS-CoV-2-Associated Coagulation Disorders?

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Role of stem-cell-derived microvesicles in the paracrine action of stem cells.

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Trichostatin A alters cytoskeleton and energy metabolism of pancreatic adenocarcinoma cells: An in depth proteomic study.

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Proteomics of extracellular vesicles: Exosomes and ectosomes.

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Diverse functions of clusterin promote and protect against the development of pulmonary fibrosis.

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Can half-marathon affect overall health? The yin-yang of sport.

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Exosomes: biogenesis, biologic function and clinical potential

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

TIMP-1 Promotes the Immune Response in Influenza-Induced Acute Lung Injury

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290

Exosomal microRNAs Drive Thrombosis in COVID-19

28 October 2021

1 reference

https://api.crossref.org/works/10.3389/fmolb.2021.632290